Kornitzer Capital Management Inc Novo Cure LTD Transaction History

Kornitzer Capital Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 29, 2021	SELL	$112.16 - $174.14 $19.5 Million - $30.3 Million	-174,035 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$58.05 - $111.31 $52,128 - $99,956	-898 Reduced 0.51%	174,035 $19.4 Million
Q2 2020 Aug 03, 2020	BUY	$57.2 - $74.41 $4.64 Million - $6.04 Million	81,193 Added 86.62%	174,933 $10.4 Million
Q1 2020 Apr 30, 2020	BUY	$57.05 - $95.75 $2.48 Million - $4.15 Million	43,390 Added 86.18%	93,740 $6.31 Million
Q4 2019 Jan 31, 2020	SELL	$68.3 - $93.8 $239,050 - $328,300	-3,500 Reduced 6.5%	50,350 $4.24 Million
Q3 2019 Nov 04, 2019	BUY	$61.86 - $97.8 $3.33 Million - $5.27 Million	53,850 New	53,850 $4.03 Million
Q4 2018 Jan 31, 2019	SELL	$28.72 - $52.63 $6.48 Million - $11.9 Million	-225,600 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$32.0 - $52.4 $16,320 - $26,724	510 Added 0.23%	225,600 $11.8 Million
Q2 2018 Aug 02, 2018	BUY	$19.85 - $32.0 $4.47 Million - $7.2 Million	225,090 New	225,090 $7.05 Million

262

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

Stay updated on Kornitzer Capital Management Inc with notifications on news.